Citations

Institution: Mayo Clinic Clear

Showing 10 of 108119 citations.

Impact of antithrombotic medications on postprocedural outcomes of percutaneous endoscopic gastrostomy: a US Collaborative Network study
Abusuliman, Mohammed , Elbenawi, Hossam , Abosheaishaa, Hazem , Mohamed, Mouhand , Nassar, Mahmoud , Elhanafi, Sherif , Mohamed, Mouhand F H , Elfert, Khaled , Abosheaishaa, Hazem Maarouf , Beran, Azizullah , Krafft, Matthew

European Journal of Gastroenterology & Hepatology | May 13, 2025 | Volume: 37 | Issue: 9 | Pages: 1021-1025

10.1097/meg.0000000000002990 | PMID 40359274 Get It

Background and aims Percutaneous endoscopic gastrostomy (PEG) is an essential procedure for patients who require long-term enteral nutrition but are unable to eat orally. However, it carries a risk of bleeding, particularly in patients on anticoagulation or dual antiplatelet therapy (DAPT). This study aimed to assess the bleeding risk associated with continuing anticoagulation or DAPT during PEG placement. Methods Using the TriNetX US Collaborative Network Database, we analyzed four cohorts: patients on anticoagulants, patients not on anticoagulants, patients on DAPT, and patients on aspirin (ASP), focusing on gastrostomy-related bleeding within 7 and 30 days, along with secondary outcomes such as mortality and the need for blood transfusion or endoscopic reintervention. Results Our analysis showed no statistically significant difference in the 7-day bleeding risk between the anticoagulant and no anticoagulant groups. However, a higher 30-day bleeding risk was observed in the anticoagulant group (0.9 vs. 0.4%, P = 0.007). There was no significant difference in the incidence of severe bleeding events requiring endoscopic intervention or blood transfusion. In addition, the difference in the bleeding risk between the DAPT and ASP groups was not statistically significant within 7 and 30 days. Conclusion These findings suggest that while anticoagulant use increases the risk of minor post-PEG bleeding, it does not lead to a higher incidence of severe bleeding. Additionally, the continuation of DAPT was not associated with statistically significant increase in bleeding risk. This study provides valuable insights into the management of antithrombotic therapy in patients undergoing PEG.
Nasal Alar and Tip Reconstruction Following Mohs Surgery Using Fresh Frozen Human Costal Cartilage Allograft: A Novel Approach
Wan, Rou , Li, Rena A. , O’Connor, Madeline J., Bartler, Angelica V., Bricker, Jonathan T., Williams, Tokoya, Alam, Murad, O’Connor, Madeline J., Galiano, Robert D.

Plastic and Reconstructive Surgery - Global Open | May 13, 2025 | Volume: 13 | Issue: 5 | Pages: e6790

10.1097/gox.0000000000006790 | PMID 40356620 Get It

Background: Skin cancer patients who undergo Mohs surgery may require subsequent reconstructive rhinoplasty for large nasal defects. Autologous cartilage is the primary source of supporting cartilage grafts, but carries the risk of potential donor-site complications. In this study, we demonstrate the safety and efficacy of nonterminally irradiated fresh frozen human costal cartilage allografts (CCAs) in reconstructive rhinoplasty after skin cancer removal. Methods: A retrospective chart review of 25 patients who underwent reconstructive rhinoplasties using human CCA after basal cell carcinoma resection was conducted. Human CCA undergoes a process of sterilization without terminal irradiation and is stored frozen (−40°C to −80°C). Anthropometric measurements were taken on pre- and postoperative photographs to evaluate nasal tip projection. Adverse events were evaluated. Results: There were 25 participants, with an average age of 71 years at the time of surgery (range: 42–90). The average follow-up duration was 12 months (range: 3–66 mo). Types of grafts used included alar batten graft (n = 17, 68%), nasal tip graft (n = 7, 28%), and alar batten graft with nasal tip graft (n = 1, 4%). Measurements on the 2-dimensional photographs of the patients showed no significant resorption or deviation at the 6- or 12-month follow-up. No significant complications related to the use of the cartilage were noted. Conclusions: Our data highlight the low complication rate and aesthetically positive outcomes from using nonterminally irradiated human CCA for reconstructive rhinoplasties in post-Mohs surgery for older patients. This approach offers a reliable source of high-quality cartilage for reconstruction.
Radiomic Parenchymal Phenotypes of Breast Texture from Mammography and Association with Risk of Breast Cancer
Winham, Stacey J. , Scott, Christopher G. , Gastounioti, Aimilia , Horng, Hannah , Norman, Aaron D. , Mankowski, Walter C. , Pantalone, Lauren , Jensen, Matthew R. , Acciavatti, Raymond J. , Cohen, Eric A. , Brandt, Kathleen R. , Vachon, Celine M. , Scott, Christopher , Gastounioti, Aimilia , Horng, Hannah , Norman, Aaron D , Mankowski, Walter C , Jensen, Matthew R , Acciavatti, Raymond J , Maidment, Andrew D A , Brandt, Kathleen R , Conant, Emily F , Kerlikowske, Karla M , Kontos, Despina , Vachon, Celine M. , Winham, Stacey J , McCarthy, Anne Marie , Maidment, Andrew D. A. , Conant, Emily F. , Kerlikowske, Karla

Radiology | May 13, 2025 | Volume: 315 | Issue: 2 | Pages: No page available

10.1148/radiol.240281 | PMID 40358450 Get It

Radiomic parenchymal phenotypes on mammograms were used to predict breast cancer risk among both Black and White women, notably for false-negative findings and symptomatic interval cancer.
Reporting guideline for the use of Generative Artificial intelligence tools in MEdical Research: the GAMER Statement
Luo, Xufei , Ranisch, Robert , Daher, Mohammad , Lam, Kyle , Eriksen, Alexander Viktor , Hsu, Che-Wei , Ozaki, Akihiko , Khanna, Sahil , Bian, Zhaoxiang , Chen, Yaolong , Estill, Janne , Litvin, Andrey , Giuffrè, Mauro , Lam, Kyle , Hsu, Che-Wei , Ozaki, Akihiko , Chen, Yaolong , Tham, Yih Chung , Moraes, Fábio Ynoe de , Su, Kuan‐Pin , Begagić, Emir

BMJ Evidence-Based Medicine | May 13, 2025 | Volume: 30 | Issue: 6 | Pages: 390-400

10.1136/bmjebm-2025-113825 | PMID 40360239 Get It

Objectives Generative artificial intelligence (GAI) tools can enhance the quality and efficiency of medical research, but their improper use may result in plagiarism, academic fraud and unreliable findings. Transparent reporting of GAI use is essential, yet existing guidelines from journals and institutions are inconsistent, with no standardised principles. Design and setting International online Delphi study. Participants International experts in medicine and artificial intelligence. Main outcome measures The primary outcome measure is the consensus level of the Delphi expert panel on the items of inclusion criteria for GAMER (Rreporting guideline for the use of Generative Artificial intelligence tools in MEdical Research). Results The development process included a scoping review, two Delphi rounds and virtual meetings. 51 experts from 26 countries participated in the process (44 in the Delphi survey). The final checklist comprises nine reporting items: general declaration, GAI tool specifications, prompting techniques, tool’s role in the study, declaration of new GAI model(s) developed, artificial intelligence-assisted sections in the manuscript, content verification, data privacy and impact on conclusions. Conclusion GAMER provides universal and standardised guideline for GAI use in medical research, ensuring transparency, integrity and quality.
Gaps and Knowledge in the Contemporary Management of Acute Right Ventricular Failure
Manca, Paolo , Mulè, Massimiliano , Sciacca, Sergio, Castrichini, Matteo , Pereira, Naveen L. , Thiele, Hölger , Jentzer, Jacob C. , Mulè, Massimiliano , Castrichini, Matteo , Pereira, Naveen L , Thiele, Holger , Jentzer, Jacob C , Cipriani, Manlio , Nuzzi, Vincenzo , Sciacca, Sergio , Schulz, Uwe

Circulation: Heart Failure | May 13, 2025 | Volume: 18 | Issue: 9 | Pages: No page available

10.1161/circheartfailure.124.012030 | PMID 40223610 Get It

Acute right ventricular failure (ARVF) is commonly seen in the intensive care unit and constitutes a significant clinical challenge, with associated high in-hospital mortality. Recently, the treatment of ARVF has significantly changed, with the progressive implementation of mechanical circulatory support devices that now represent important tools for clinicians in treating this condition. However, despite recent advancements, the optimal approach for ARVF remains elusive, and precise treatment algorithms and comprehensive management protocols are still lacking. In the present review, we explore the pathophysiology of ARVF, highlighting the different mechanisms that may lead to this clinical entity and emphasizing the left and right heart’s complex interplay. We analyze the different therapeutic options that are now available for short- and long-term management of ARVF, with a particular focus on the advantages and disadvantages of the mechanical circulatory support devices actually used. Furthermore, we propose future directions in the field and a possible flowchart for the treatment of this condition.
From embedded interprofessional clinics to expanded alcohol-associated liver disease programs
Winder, Gerald Scott , Banerjee, Arpita Goswami, Bryce, Kelly , Fipps, David C. , Hussain, Filza, Omary, Lesley, Patel, Shivali , Rubman, Susan , Shenoy, Akhil , Suzuki, Joji , Zimbrean, Paula C. , Brown, Kimberly , Mellinger, Jessica L. , Hussain, Filza , Im, Gene , Patel, Arpan , Serper, Marina , Shenoy, Akhil , Suzuki, Joji , Abouljoud, Marwan , Mellinger, Jessica , Winder, Scott , Fipps, David C , Arab, Juan Pablo , Patel, Arpan , Serper, Marina

Liver Transplantation | May 13, 2025 | Volume: 31 | Issue: 12 | Pages: 1567-1580

10.1097/lvt.0000000000000638 | PMID 40359009 Get It

Hazardous alcohol use remains a major contributor to acute and chronic liver disease, while alcohol-associated liver disease (ALD) is a leading indication for liver transplantation. In recent years, embedded, interprofessional ALD clinics have improved access to alcohol use disorder care within hepatology and liver transplantation, but more work is needed to meet this challenge. The literature is lacking regarding scaling procedures to provide services for increasingly large ill patient populations. This article begins to fill this gap by describing “expanded ALD care”: broad, innovative, longitudinal, interprofessional care delivery strategies surpassing standalone clinics. Drawing from analogous patient populations served by collaborative models in primary care and comprehensive eating disorder treatment, the expanded ALD care framework proposes practical strategies toward specific innovations: equipoise between biomedical and psychosocial care elements, increased clinician number and reach, long-term patient relationships, harm reduction and palliative care, outreach to external agencies and clinicians, and enhanced support for patients and families. The article also defines attributes of innovative healthcare systems that support expanded ALD care.
Robotic Totally Endoscopic Reverse Hybrid Coronary Revascularization: Early and Midterm Outcomes
Nisivaco, Sarah, Bhasin, Riya , Kitahara, Hiroto , Nathan, Sandeep , Balkhy, Husam H. , AlJamal, Yazan N , Nisivaco, Sarah , Bhasin, Riya , Balkhy, Husam H , AlJamal, Yazan

Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery | May 13, 2025 | Volume: 20 | Issue: 3 | Pages: 276-282

10.1177/15569845251334117 | PMID 40359074 Get It

Objective: Reverse hybrid coronary revascularization (RHCR) is the integration of percutaneous coronary intervention (PCI) followed by sternal-sparing coronary artery bypass grafting in patients with multivessel coronary artery disease (CAD). We sought to review our RHCR experience over a 10-year period using PCI first followed by robotic totally endoscopic coronary artery bypass (TECAB). Methods: We reviewed the indications and outcomes in patients who underwent RHCR (PCI with drug-eluting stents first, followed by TECAB). Results: From July 2013 to August 2024, 882 robotic TECAB procedures were performed at our institution. Of these, 60 patients underwent RHCR. The mean age of the patients was 66.7 ± 10 years, and 74% were male patients. The target vessel stented was the right coronary artery in 52 patients (87%), circumflex coronary artery in 10 patients (17%), and diagonal in 4 patients (7%). The average time from PCI to TECAB was 3.8 ± 1.64 months. A total of 35 patients (58%) underwent multivessel grafting, with 74% bilateral internal thoracic artery (ITA) use. The mean operative time was 253 ± 88 min, and the mean hospital length of stay was 2 ± 0.76 days. There were no conversions, perioperative strokes, or myocardial infarctions. At mean follow-up of 34 ± 27 months, cardiac-related mortality occurred in 1 patient. Freedom from major adverse cardiac or cerebrovascular events including repeat revascularization was 93%. Conclusions: RHCR is safe and feasible in selected patients with multivessel CAD. In experienced hands, stenting first followed by robotic TECAB with left ITA or bilateral ITA grafts resulted in excellent early and midterm outcomes. Further studies are warranted.
Global Sociodemographic Disparities in Ischemic Heart Disease Mortality According to Sex, 1980 to 2021
Sayed, Ahmed , Michos, Erin D. , Návar, Ann Marie , Virani, Salim S. , Brewer, LaPrincess C. , Manson, JoAnn E. , Manson, JoAnn E , Brewer, LaPrincess C , Michos, Erin D , Navar, Ann Marie

Circulation: Cardiovascular Quality and Outcomes | May 13, 2025 | Volume: 18 | Issue: 7 | Pages: No page available

10.1161/circoutcomes.124.011648 | PMID 40358980 Get It

BACKGROUND: Mortality due to ischemic heart disease (IHD) has declined in countries with high socioeconomic development. Whether these declines extend to other settings, and whether socioeconomic development influences IHD mortality among men and women differently, is unknown. METHODS: We obtained annual data on sex-specific IHD mortality rates for countries/territories in the GBD study (Global Burden of Disease) from 1980 to 2021. The sociodemographic index (SI), a measure of socioeconomic development, was retrieved for each country/territory. Age-adjusted IHD mortality rates were modeled as a smooth function of sex, year, and SI. RESULTS: From 1980 to 2021, IHD mortality rates did not decrease in low SI settings for men or women. In contrast, mortality rates relative to 1980 declined by >25% in average SI settings (age-adjusted mortality per 100 000, 153–107 for women and 218–161 for men) and >50% in high SI settings (age-adjusted mortality per 100 000, 162–69 for women and 258–114 for men). Comparing the 20th versus 80th percentile of SI in 2021 (corresponding to lower versus higher socioeconomic development), mortality rates were 81% higher for men and 111% higher for women living in socioeconomically deprived settings ( P for difference by sex: 0.01), although absolute differences were larger in men. The association of low SI with higher IHD mortality was especially pronounced for mortality attributable to environmental/occupational risk factors (eg, particulate matter air pollution, lead exposure, and extremes of temperature), with mortality rates being 174% higher among women and 199% higher among men. CONCLUSIONS: Across the past 4 decades, low socioeconomic development was associated with no improvement in IHD mortality rates for men or women, in contrast to the large reductions observed in settings with high socioeconomic development. In contemporary settings, socioeconomic deprivation is associated with larger relative excess mortality in women and larger absolute excess mortality in men.
A Phase II Multicenter Trial of Trabectedin in Combination with Olaparib in Patients with Advanced Unresectable or Metastatic Sarcoma
Siontis, Brittany L. , Rice, John D. , Schuetze, Scott M. , Rottmann, Douglas , Angeles, Christina V. , Fox, Amanda K. , Zyczynski, Laurie E. , Hayek, Salim S. , Robinson, Steven I. , Okuno, Scott H. , Ho, Thanh P. , Hayek, Salim , Chugh, Rashmi , Siontis, Brittany L , Robinson, Steven I , Chugh, Rashmi

Clinical Cancer Research | May 13, 2025 | Volume: 31 | Issue: 14 | Pages: 2919-2925

10.1158/1078-0432.ccr-25-0298 | PMID 40358615 Get It

Abstract Purpose: Soft-tissue sarcomas are rare malignancies with poor prognosis and limited systemic treatment options. We conducted a phase II study to assess the efficacy and safety of trabectedin and olaparib in patients with advanced disease. Patients and Methods: Patients with soft-tissue sarcoma who received ≥1 prior therapy were recruited into two cohorts. Cohort 1 included leiomyosarcoma and liposarcoma; cohort 2 included other histologies. All patients received trabectedin (1.1 mg/m2 24-hour infusion every 21 days) and olaparib (150 mg twice daily continuously). The study was conducted using a Simon minimax two-stage design with a primary endpoint of objective response (OR) rate per RECIST 1.1. Results: Twenty-nine (cohort 1, 16; cohort 2, 13) patients enrolled; one patient in cohort 2 was not evaluable. There were no confirmed ORs in cohort 1; the best response was stable disease in 12 (75%) patients and progressive disease in four (25%). Two partial responses were observed in cohort 2 (n = 12). The most common adverse events were fatigue (75%), neutropenia (75%), anemia (68%), and thrombocytopenia (68%). The median progression-free survival and overall survival for all patients were 3.5 (95% confidence interval, 3.3–8.2) and 13.2 months (95% confidence interval, 10.3–20.9), respectively. Next-generation sequencing of 17 tumors revealed multiple abnormalities, most commonly in TP53, RB1, and ATRX. Conclusions: Trabectedin plus olaparib conferred high rates of toxicity and failed to demonstrate ORs in leiomyosarcoma and liposarcoma. Preliminary evidence of clinical benefit in two patients in cohort 2 suggests potential value of either or both drugs in other sarcomas.
Matching Patients with Surgeons: Heterogeneous Effects of Surgical Volume on Surgery Duration
Pourghannad, Behrooz , Wang, Guihua

Manufacturing & Service Operations Management | May 13, 2025 | Volume: 27 | Issue: 4 | Pages: 1037-1052

10.1287/msom.2023.0019 Get It

Problem definition: We study how to leverage patient-specific information to improve a hospital’s operational efficiency. We use abdominal surgery as the clinical setting and study the heterogeneous effects of surgical volume on surgery duration. We develop a framework for using patient-specific information by addressing three important questions: (1) Is the effect of surgical volume heterogeneous across patients with different features? (2) If so, how could patient-specific information that captures the heterogeneous effects of surgical volume on surgery duration be generated? (3) What is the value of patient-specific information in helping a hospital improve its operational efficiency? Methodology/results: Using an instrumental variable approach to address potential endogeneity issues, we first use a regression model to show that the average effect of surgical volume on surgery duration is significant. Then, we use a regression model with interaction terms to show that the effect of surgical volume is heterogeneous. After that, we apply an instrumental variable forest approach to obtain patient-specific volume effects. Finally, we use patient-specific volume effects and an optimization model to assess the potential value of patient-specific information in improving a hospital’s operational efficiency. We find the that total duration of surgeries could be reduced by 2.5%–8.9% if patient-specific volume effects are considered. Managerial implications: This study provides a framework for understanding treatment effect heterogeneity and using patient-specific information to improve a hospital’s operational efficiency. We provide empirical evidence that the effect of surgical volume is heterogeneous and address the challenges of estimating heterogeneous effects for different patients. Our framework can help hospital administrators to better match patients with surgeons, improving a hospital’s operational efficiency. Supplemental Material: The online appendix is available at https://doi.org/10.1287/msom.2023.0019 .